Richard C Duke

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Globeimmune, Inc., University of Colorado, University Technology Corporation. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard C Duke. Retrieved from https://idiyas.com/inventor/richard-c-duke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 47.1

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 11

Forward Citations = 416(Granted Patents)

Company Filing History:

University of Colorado

patents

3 out of 87

University Technology Corporation

patents

4. 1 out of 1

Apoplogic Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 1998-2019

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10352936 - Use of tumor Fas expression to determine response to anti-cancer therapy (2019-07-16),

2. 9216206 - Methods of treating symptoms associated with menopause and hormonal variations with G-CSF (2015-12-22),

3. 8821892 - Yeast-based therapeutic for chronic hepatitis C infection (2014-09-02),

4. 8728489 - Immunotherapy for chronic hepatitis C virus infection (2014-05-20),

5. 8715645 - Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same (2014-05-06),

6. 8388980 - Yeast-based therapeutic for chronic hepatitis C infection (2013-03-05),

7. 8221763 - Yeast-antigen compositions and methods of using the same (2012-07-17),

8. 8007816 - Yeast-based therapeutic for chronic hepatitis C infection (2011-08-30),

9. 7736642 - Yeast-based vaccine for inducing an immune response (2010-06-15),

10. 7632511 - Yeast-based therapeutic for chronic hepatitis C infection (2009-12-15),

11. 7625569 - Yeast-based therapeutic for chronic hepatitis C infection (2009-12-01),

12. 7595060 - Yeast-antigen compositions methods of making the same (2009-09-29),

13. 7439042 - Yeast-based therapeutic for chronic hepatitis C infection (2008-10-21),

14. 7083787 - Yeast-dendritic cell vaccines and uses thereof (2006-08-01),

15. 6325999 - Use of Fas ligand to suppress T-lymphocyte-mediated immune responses (2001-12-04),

Title: The Innovative Journey of Richard C Duke

Introduction: Richard C Duke, a pioneering inventor based in Denver, CO (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Richard C Duke's latest patents include cutting-edge solutions in the fields of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Richard C Duke has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His passion for pushing the boundaries of technology has led to the successful commercialization of several of his inventions.

Collaborations: Throughout his career, Richard C Duke has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: Richard C Duke's relentless pursuit of innovation and his commitment to creating a positive impact on society through his inventions make him a true trailblazer in the world of technology. His work continues to inspire the next generation of inventors to think outside the box and push the boundaries of what is possible.

Profile summary based on public USPTO records.